Cancer vaccines: should we be targeting patients with less aggressive disease? (Q38032880)

27 August 2017

Cancer vaccines: should we be targeting patients with less aggressive disease? (English)

1 reference

27 August 2017

Diane F Hale

1

1 reference

27 August 2017

G Travis Clifton

2

1 reference

27 August 2017

Alan K Sears

3

1 reference

27 August 2017

Timothy J Vreeland

4

1 reference

27 August 2017

Nathan Shumway

5

1 reference

27 August 2017

George E Peoples

6

1 reference

27 August 2017

Elizabeth A Mittendorf

7

1 reference

27 August 2017

1 June 2012

1 reference

Expert Review of Vaccines

27 August 2017

1 reference

27 August 2017

11

1 reference

27 August 2017

721-731

1 reference

27 August 2017

6

1 reference

Coley's toxins, tumor necrosis factor and cancer research: a historical perspective

27 August 2017

1 reference

Cancer; a biological approach. I. The processes of control

21 January 2018

1 reference

Cancer immunoediting: from immunosurveillance to tumor escape

21 January 2018

1 reference

The immune system--is it relevant to cancer development, progression and treatment?

21 January 2018

1 reference

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

21 January 2018

1 reference

A multipeptide vaccine is safe and elicits T-cell responses in participants with advanced stage ovarian cancer

21 January 2018

1 reference

Cytolytic T-cell responses of cancer patients vaccinated with a MAGE antigen.

21 January 2018

1 reference

Down-regulation of HLA Class I and NKG2D ligands through a concerted action of MAPK and DNA methyltransferases in colorectal cancer cells.

21 January 2018

1 reference

HLA class I antigen loss, tumor immune escape and immune selection

21 January 2018

1 reference

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

21 January 2018

1 reference

Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

21 January 2018

1 reference

Clinical trial results of the HER-2/neu (E75) vaccine to prevent breast cancer recurrence in high-risk patients: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02

21 January 2018

1 reference

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

21 January 2018

1 reference

Antigen-based immunotherapy of melanoma: Canvaxin therapeutic polyvalent cancer vaccine

21 January 2018

1 reference

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma

21 January 2018

1 reference

Immunological factors in human sarcomas and melanomas: a rational basis for immunotherapy

21 January 2018

1 reference

Improved endpoints for cancer immunotherapy trials

21 January 2018

1 reference

Immunology and breast cancer: therapeutic cancer vaccines.

21 January 2018

1 reference

Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer

21 January 2018

1 reference

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

21 January 2018

1 reference

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma

21 January 2018

1 reference

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

21 January 2018

1 reference

Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise

21 January 2018

1 reference

A newly identified MAGE-3-derived, HLA-A24-restricted peptide is naturally processed and presented as a CTL epitope on MAGE-3-expressing gastrointestinal cancer cells

21 January 2018

1 reference

Structure, chromosomal localization, and expression of 12 genes of the MAGE family

21 January 2018

1 reference

Identification of an immunodominant peptide of HER-2/neu protooncogene recognized by ovarian tumor-specific cytotoxic T lymphocyte lines

21 January 2018

1 reference

The E75 HER2/neu peptide vaccine

21 January 2018

1 reference

Mechanisms of T-cell inhibition: implications for cancer immunotherapy

21 January 2018

1 reference

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

21 January 2018

1 reference

CTLA-4 can function as a negative regulator of T cell activation

21 January 2018

1 reference

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

Immune-mediated eradication of tumors through the blockade of transforming growth factor-beta signaling in T cells

21 January 2018

1 reference

Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice

21 January 2018

1 reference

FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis.

21 January 2018

1 reference

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.

21 January 2018

1 reference

Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer

21 January 2018

1 reference

Methylation of the promoter of human leukocyte antigen class I in human esophageal squamous cell carcinoma and its histopathological characteristics.

21 January 2018

1 reference

Immunofluorescence-detected infiltration of CD4+FOXP3+ regulatory T cells is relevant to the prognosis of patients with endometrial cancer.

21 January 2018

1 reference

The prognostic impact of Akt isoforms, PI3K and PTEN related to female steroid hormone receptors in soft tissue sarcomas

21 January 2018

1 reference

Assessment of immunologic response and recurrence patterns among patients with clinical recurrence after vaccination with a preventive HER2/neu peptide vaccine: from US Military Cancer Institute Clinical Trials Group Study I-01 and I-02.

21 January 2018

1 reference

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets

21 January 2018

1 reference

Tumor-Infiltrating FOXP3+ T Regulatory Cells Show Strong Prognostic Significance in Colorectal Cancer

21 January 2018

1 reference

Quantification of Regulatory T Cells Enables the Identification of High-Risk Breast Cancer Patients and Those at Risk of Late Relapse

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.12.39

1 reference

27 August 2017

1 reference